FNArena Windows
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
| ASX CODE | LAST PRICE | % MOVE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET | UPSIDE/DOWNSIDE |
|---|---|---|---|---|---|---|---|
| 4DX | $3.80 |
|
$7.55 | $1.40 | -65.3 |
$4.50 |
|
| ACL | $2.88 |
|
$3.03 | $1.83 | 15.4 |
$2.65 |
|
| ACR | $0.01 | 0.00% | $0.02 | $0.01 |
|
||
| ACW | $0.06 | 0.00% | $0.07 | $0.03 |
|
||
| ADO | $0.02 | 0.00% | $0.05 | $0.01 |
|
||
| AFP | $3.54 |
|
$4.13 | $2.30 |
|
||
| AGN | $0.15 | 0.00% | $0.35 | $0.09 |
|
||
| ALC | $0.10 | 0.00% | $0.14 | $0.08 | 50.0 |
$0.15 |
|
| ARX | $0.53 |
|
$0.80 | $0.50 | 35.9 |
$0.94 |
|
| AT1 | $0.02 | 0.00% | $0.05 | $0.02 |
|
||
| ATH | $0.42 |
|
$0.79 | $0.01 |
|
||
| AVE | $0.02 | 0.00% | $0.03 | $0.01 |
|
||
| AVH | $2.96 |
|
$3.08 | $1.00 |
$2.95 |
|
|
| AYA | $3.64 | 0.00% | $6.49 | $2.12 |
$6.00 |
|
|
| BB1 | $0.69 |
|
$1.11 | $0.51 |
$1.76 |
|
|
| BIO | $0.43 |
|
$0.53 | $0.20 | 26.9 |
$0.75 |
|
| BMT | $0.11 | 0.00% | $0.24 | $0.08 |
|
||
| BOT | $0.02 | 0.00% | $0.17 | $0.02 |
|
||
| BRN | $0.13 | 0.00% | $0.27 | $0.11 |
|
||
| CAT | $2.91 | 0.00% | $7.72 | $2.74 |
$5.16 |
|
|
| CBL | $0.06 | 0.00% | $0.10 | $0.03 |
|
||
| CGS | $3.29 |
|
$3.38 | $1.75 | 24.7 |
$3.70 |
|
| CMP | $0.23 | 0.00% | $0.45 | $0.22 |
|
||
| COH | $136.39 |
|
$296.91 | $88.74 | 26.1 |
$138.537 |
|
| COV | $0.33 |
|
$0.90 | $0.29 |
|
||
| CSL | $177.56 |
|
$222.47 | $90.00 | 20.0 |
$167.673 |
|
| CSX | $0.40 |
|
$0.78 | $0.32 |
|
||
| CTE | $1.17 |
|
$1.40 | $0.80 |
|
||
| CU6 | $2.10 |
|
$5.87 | $1.80 |
$6.40 |
|
|
| CUV | $8.16 |
|
$13.48 | $7.93 | 12.5 |
$10.75 |
|
| CVB | $0.03 |
|
$0.13 | $0.02 |
|
||
| DOC | $0.12 | 0.00% | $0.20 | $0.11 | 12.7 |
$0.22 |
|
| DXB | $0.25 |
|
$0.67 | $0.16 |
|
||
| EBO | $16.31 |
|
$26.75 | $15.68 | 13.5 |
$23.81 |
|
| EBR | $0.25 | 0.00% | $1.47 | $0.24 |
$1.275 |
|
|
| EGH | $0.65 |
|
$0.80 | $0.45 | 16.5 |
$0.85 |
|
| EIQ | $0.59 |
|
$1.88 | $0.17 |
$0.983 |
|
|
| EMV | $1.65 |
|
$2.16 | $1.47 |
$3.15 |
|
|
| EYE | $0.14 | 0.00% | $0.21 | $0.10 |
|
||
| FPH | $35.55 |
|
$37.71 | $26.51 | 44.7 |
|
|
| GSS | $0.07 |
|
$0.43 | $0.05 |
$0.10 |
|
|
| HLS | $0.45 | 0.00% | $1.07 | $0.30 |
$0.48 |
|
|
| IDT | $0.05 | 0.00% | $0.07 | $0.03 |
|
||
| IDX | $2.32 |
|
$2.97 | $1.91 | 17.7 |
$3.375 |
|
| ILA | $0.42 |
|
$0.63 | $0.31 |
|
||
| IME | $0.30 |
|
$0.47 | $0.23 |
$0.37 |
|
|
| IMM | $0.05 | 0.00% | $0.47 | $0.03 |
$0.06 |
|
|
| IMR | $1.80 |
|
$2.25 | $1.28 |
$2.90 |
|
|
| IMU | $0.05 | 0.00% | $0.46 | $0.05 |
$0.25 |
|
|
| INA | $4.17 |
|
$5.88 | $3.49 | 11.2 |
$4.89 |
|
| IPD | $0.01 | 0.00% | $0.06 | $0.00 |
$0.015 |
|
|
| IVX | $0.05 | 0.00% | $0.12 | $0.03 |
|
||
| LDX | $0.11 | 0.00% | $0.33 | $0.08 |
$0.25 |
|
|
| LGP | $0.07 | 0.00% | $0.15 | $0.06 |
|
||
| LIC | $4.73 |
|
$6.16 | $4.47 | 22.3 |
$5.588 |
|
| M7T | $0.23 |
|
$0.69 | $0.22 |
$0.48 |
|
|
| MAP | $0.05 | 0.00% | $0.11 | $0.04 |
$0.085 |
|
|
| MPL | $4.61 |
|
$5.31 | $4.06 | 18.3 |
$5.214 |
|
| MSB | $2.06 |
|
$3.31 | $1.88 | 29.2 |
$4.45 |
|
| MVF | $0.79 |
|
$0.90 | $0.58 | 16.3 |
$0.807 |
|
| MVP | $0.49 |
|
$0.77 | $0.37 | 121.3 |
$1.00 |
|
| MX1 | $0.02 | 0.00% | $0.12 | $0.01 |
$0.06 |
|
|
| MYX | $3.02 |
|
$6.50 | $2.04 |
|
||
| NAN | $2.89 | 0.00% | $4.76 | $2.64 | 74.1 |
$3.633 |
|
| NEU | $20.54 |
|
$23.76 | $11.00 | 52.3 |
$25.867 |
|
| NHF | $6.55 |
|
$7.73 | $5.79 | 14.4 |
$7.36 |
|
| NUZ | $0.08 | 0.00% | $0.17 | $0.05 |
$0.20 |
|
|
| OCA | $0.53 | 0.00% | $0.82 | $0.52 |
|
||
| OCC | $0.70 | 0.00% | $1.60 | $0.67 |
$1.13 |
|
|
| ONE | $0.16 |
|
$0.41 | $0.13 |
$0.42 |
|
|
| OSL | $0.97 | 0.00% | $2.09 | $0.37 |
|
||
| PAR | $0.25 | 0.00% | $0.47 | $0.14 |
$0.42 |
|
|
| PCK | $0.12 | 0.00% | $0.35 | $0.04 |
|
||
| PEB | $0.21 | 0.00% | $0.27 | $0.12 |
|
||
| PER | $0.00 | 0.00% | $0.01 | $0.00 |
|
||
| PGC | $0.14 | 0.00% | $0.33 | $0.13 | 7.9 |
$0.23 |
|
| PME | $169.22 |
|
$321.57 | $107.75 | 85.2 |
$225.833 |
|
| PNV | $0.95 |
|
$1.66 | $0.81 | 60.3 |
$1.21 |
|
| PYC | $2.40 |
|
$2.62 | $0.90 |
$3.55 |
|
|
| RAC | $2.02 |
|
$4.90 | $1.91 |
|
||
| RAP | $0.02 | 0.00% | $0.07 | $0.02 |
|
||
| RCE | $0.34 | 0.00% | $0.73 | $0.32 |
|
||
| REG | $4.80 |
|
$9.40 | $3.85 | 25.9 |
$5.95 |
|
| RHC | $55.13 |
|
$55.98 | $30.39 | 31.8 |
$49.682 |
|
| RMD | $32.04 |
|
$43.29 | $25.50 | 18.3 |
$38.875 |
|
| RYM | $1.58 |
|
$2.64 | $1.54 |
|
||
| SHG | $0.18 |
|
$0.35 | $0.17 |
|
||
| SHL | $19.62 |
|
$24.27 | $18.26 | 15.9 |
$22.543 |
|
| SLD | $0.42 | 0.00% | $1.56 | $0.36 |
$1.885 |
|
|
| SNT | $0.02 | 0.00% | $0.04 | $0.02 |
$0.06 |
|
|
| SNZ | $6.20 |
|
$12.09 | $5.75 | 7.4 |
|
|
| SOM | $0.35 |
|
$0.95 | $0.30 | 15.2 |
$0.76 |
|
| SPL | $0.77 |
|
$0.83 | $0.12 |
|
||
| TLX | $17.45 |
|
$18.32 | $8.26 | 274.4 |
$23.29 |
|
| TRJ | $0.18 |
|
$0.87 | $0.15 | 5.6 |
$0.55 |
|
| TRP | $0.08 | 0.00% | $0.48 | $0.06 |
|
||
| VIT | $0.02 | 0.00% | $0.07 | $0.02 |
|
||
| ZNO | $0.06 | 0.00% | $0.18 | $0.03 |
|
7.34% 
-8.0% Previous Stories
Anti-Vaxxers & China Cloud CSL’s Future
Oct 31 2025
Falling vaccination rates in the US prompted a guidance downgrade at CSL, but was the market’s reaction excessive?
Rudi Interviewed: Diary Of A Successful Investor
Oct 20 2025
FNArena Editor Rudi Filapek-Vandyck was interviewed by Peter Switzer as the opening act in a new series titled The Diary of a Successful Investor
Acquisition Loads Up Catapult
Oct 20 2025
In its latest acquisition, Catapult Sports has added the missing element to make it a globally competitive sports software company
Is CSL Starting Its Price Recovery?
Sep 30 2025
As bruised CSL shareholders would attest to, the biotech has been challenged. Fairmont Equities’ Michael Gable reports signs of a turnaround are in place
Undervalued ASX Gems In Precision Medicine
Sep 23 2025
Flighty investors have caused share prices to fall in 2025, but MPC Markets’ Mark Gardner sees better futures ahead for two ASX-listed companies involved in cancer prevention and treatment
Earnings Result Leaves CSL Bloodied
Aug 21 2025
Uncertain Behring growth, lower vaccine sales and a controversial restructuring plan led to a post-result share price drubbing. Is it all over for CSL?
Cochlear’s Future In Nexa’s Hands
Aug 19 2025
Following a weak FY25, and weak FY26 guidance, Cochlear’s outlook rests on the success of its new Nexa implant and other products. Is the market too confident?
ResMed’s New Level Of Support
Jul 29 2025
Michael Gable of Fairmont Equities reports buying the dip remains a valid strategy for ResMed shares above new technical support of $40
Healthcare’s Challenge: Antimicrobial Resistance
Jul 23 2025
Surging Antimicrobial resistance is expected to cost US$3bn to US$4bn over the next decade and lower GDP of low-and middle-income countries, Federated Hermes warns
Renewed Momentum For CSL Shares
Jul 22 2025
Michael Gable of Fairmont Equities suggests CSL shares have found a bottom and seem destined for $300-plus yet again
Latest News
| 1 |
ASX Winners And Losers Of Today – 17-09-266:35 PM - Daily Market Reports |
| 2 |
ESG Focus: From Ambition To Monetisation11:15 AM - ESG Focus |
| 3 |
The Short Report – 17 Sep 202611:00 AM - Weekly Reports |
| 4 |
Hancock Deal Reshapes Strike Energy’s Outlook10:45 AM - Commodities |
| 5 |
Australian Broker Call *Extra* Edition – Sep 17, 202610:30 AM - Daily Market Reports |